E-ISSN 2146-9369 | ISSN 2146-3158
 

Research Article 


Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia.

Abstract
Objective: Antibiotic resistance is a global phenomenon wherein physicians face the most challenging decision to make for the right kind of drug, and its combinations, to tackle the ever growing ESBL and NDM on pathogens. The aim of the study is to understand outcome of hospitalized patients undergoing antibiotic therapy for bacterial infections. These patients are from Kamrup District of Assam, India.<br>Materials and methods: A total of 185 clinical isolates of Escherichia coli and Klebsiella pneumoniae were collected from hospitalized patients of a tertiary care centre presenting symptoms of infection. Upon biochemical identification, their antibiotic susceptibility were assessed; isolates resistant to 3rd or 4th generation cephalosporins or carbapenem were phenotypically and genotypically determined for the production of extended spectrum β-lactamase (ESBL) and carbapenemase. PCR was carried out for CTX-M, TEM, SHV, OXA-48 and New Delhi Metallo-β-lactamase (NDM).<br>Results: Bacterial infection is ubiquitous among male and female patients, with high isolation rate of Escherichia coli among female patients with urinary infection. The highest resistance against E. coli isolates was nalidixic acid (82.9%; p≤0.005) and cefixime (81.4%; p≤0.005). The highest resistance against K. pneumoniae was cefotaxime (77.7%; p≤0.005) and ceftazidime (73%; p≤0.005). Imipenem was the most effective antibiotic while ertapenem was the least. Antibiotic therapy included piperacillin (alone or in combination with tazobactam) for both E. coli and K. pneumoniae infections.<br>Conclusions: Ceftriaxone, amikacin, cefepime, ceftriazone and imipenem were chosen as treatment options; isolates showed intermediate to negligible resistance to these drugs. Tigecycline was administered to patients infected with NDM producing pathogens. J Microbiol Infect Dis 2018; 8(4): 153-157.

Key words: antibacterial agents, drug resistance, ESBL, NDM


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Vedant Vikrom Borah
Articles by Mrinal Kumar Baishya
Articles by Kandarpa Kumar Saikia
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia. Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre. J Microbiol Infect Dis. 2018; 8(4): 153-157 . doi:10.5799/jmid.493854


Web Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia. Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre. https://www.jmidonline.org/?mno=302657186 [Access: February 04, 2024]. doi:10.5799/jmid.493854


AMA (American Medical Association) Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia. Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre. J Microbiol Infect Dis. 2018; 8(4): 153-157 . doi:10.5799/jmid.493854



Vancouver/ICMJE Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia. Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre. J Microbiol Infect Dis. (2018), [cited February 04, 2024]; 8(4): 153-157 . doi:10.5799/jmid.493854



Harvard Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia (2018) Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre. J Microbiol Infect Dis, 8 (4), 153-157 . doi:10.5799/jmid.493854



Turabian Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia. 2018. Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre. Journal of Microbiology and Infectious Diseases, 8 (4), 153-157 . doi:10.5799/jmid.493854



Chicago Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia. "Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre." Journal of Microbiology and Infectious Diseases 8 (2018), 153-157 . doi:10.5799/jmid.493854



MLA (The Modern Language Association) Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia. "Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre." Journal of Microbiology and Infectious Diseases 8.4 (2018), 153-157 . Print. doi:10.5799/jmid.493854



APA (American Psychological Association) Style

Vedant Vikrom Borah, Mrinal Kumar Baishya, Kandarpa Kumar Saikia (2018) Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Centre. Journal of Microbiology and Infectious Diseases, 8 (4), 153-157 . doi:10.5799/jmid.493854